Ruxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts

MeSH terms

• Aged, 80 and over
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Azacitidine / administration & dosage
• Azacitidine / analogs & derivatives
• DNA Modification Methylases / antagonists & inhibitors
• Decitabine
• Fatigue / prevention & control
• Female
• Follow-Up Studies
• Humans
• Male
• Middle Aged
• Nitriles
• Primary Myelofibrosis / drug therapy*
• Primary Myelofibrosis / pathology
• Pyrazoles / administration & dosage
• Pyrimidines
• Remission Induction
• Treatment Outcome